Cargando…
P1533: TRIAL IN PROGRESS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PARSACLISIB IN PATIENTS WITH PRIMARY WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Autores principales: | Barcellini, W., Butler, K., Moran, S., Bibeau, K., Dzhindzhikhashvili, I., Wei, S., Jäger, U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431322/ http://dx.doi.org/10.1097/01.HS9.0000848988.44172.ff |
Ejemplares similares
-
The Changing Landscape of Autoimmune Hemolytic Anemia
por: Barcellini, Wilma, et al.
Publicado: (2020) -
Diagnosis and Management of Autoimmune Hemolytic Anemias
por: Barcellini, Wilma, et al.
Publicado: (2022) -
New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia
por: Barcellini, Wilma
Publicado: (2015) -
Immunotherapy Treatments of Warm Autoimmune Hemolytic Anemia
por: Liu, Bainan, et al.
Publicado: (2013) -
Educational Case: Warm Autoimmune Hemolytic Anemia
por: Arays, Ruta, et al.
Publicado: (2020)